Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    keynote 199
Previous Study | Return to List | Next Study

Study of Pembrolizumab (MK-3475) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(MK-3475-199/KEYNOTE-199)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02787005
Recruitment Status : Active, not recruiting
First Posted : June 1, 2016
Last Update Posted : February 12, 2021
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.